Delin Ventures
Early-stage investor running separate funds for cell therapy and future-of-work technology.
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Pre-seed, Seed
- Sector focus
- Biotech & Life Sciences, SaaS & B2B, HR & Future of Work, Media & Gaming
- Cheque size
- €100k–€1.5M
- Fund size
- Undisclosed
- Founded
- 2015
- Website
- delinventures.com
Delin Ventures is an early-stage investor with a presence in London and Cambridge that runs two strategies. Its Life Sciences fund builds and backs companies in cell therapy, covering therapeutics, services and manufacturing technologies, investing from pre-seed onwards; reported initial tickets reach up to £5m at seed with follow-on capacity through Series A.
Its Technology fund backs the future of work and learning, including HR tech, productivity tools, workforce development and upskilling platforms, typically leading pre-seed and seed rounds of up to £2m. The firm invests mainly in European start-ups.
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.